| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2879897 | The Annals of Thoracic Surgery | 2008 | 8 Pages |
Abstract
Compared with placebo, aprotinin use was associated with less MACCE but more AKI after OPCAB. The strong relationship between the peak aprotinin level and subsequent AKI suggests weight-based protocols for dosing aprotinin may reduce this risk.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael C. BS, Zachary BA, Ashish MD, PhD, Eric BS, Seeta MD, Nicholas BS, Junyan MD, PhD, Robert S. MD,